Novel Agent Promising as Add-On Epilepsy Treatment

(MedPage Today) -- A novel selective potassium channel opener appeared promising against focal-onset seizures when given atop other epilepsy medications, according to a phase IIb trial. Treatment with the small-molecule agent XEN1101 reduced monthly...
Source: MedPage Today Neurology - Category: Neurology Source Type: news